Catheter Precision, Inc. VTAK 深 滬
已收盤 05-22 16:00:00 美东时间
0.848
+0.053
+6.71%
華盛通- 最 高0.8551
- 今 開0.85
- 成交量 3.84万股
- 最 低 0.7935
- 昨 收 0.7947
- 總市值 228.32万
- 52周最高 15.6807
- 市盈率 靜 --
- 換手率 1.42%
- 52周最低 0.7501
- 委 比 0.00%
- 總股本 269.25万
- 歷史最高 5225000.00
- 量 比 0.18
- 振 幅 7.75%
- 歷史最低 0.7501
- 每 手 1
- 風險率 1.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Catheter Precision, Inc. Common Stock Q1 EPS $(1.39) Up From $(6.84) YoY, Sales $432.000K Up From $143.000K YoY
Catheter Precision, Inc. Common Stock (AMEX:VTAK) reported quarterly losses of $(1.39) per share. This is a 79.68 percent increase over losses of $(6.84) per share from the same period last year. The company reported
05-19 05:23
Catheter Precision's Flyte Expands Flights Capacity And Launches Hiring Initiative After Spirit Airlines Shutdown
Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), today announced increased flight capacity and the launch of a targeted hiring initiative following the
05-04 22:32
美股夜盘 | 柏雅国际涨85.04%，Aspire Biopharma Holdings, Inc.涨23.71%
柏雅国际涨85.04%；Aspire Biopharma Holdings, Inc.涨23.71%；Epsium Enterprise涨20.30%
04-21 15:01
Catheter Precision Engages Strategic Advisor To Formally Market For Sale Its Cardiac Electrophysiology Business
Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company") today announced that it has engaged a strategic advisor to formally market for sale its cardiac electrophysiology business. This strategic initiative is
04-02 20:08
Catheter Precision Q4 EPS $(2.88) Up From $(21.66) YoY, Sales $238.000K Up From $149.000K YoY
Catheter Precision (AMEX:VTAK) reported quarterly losses of $(2.88) per share. This is a 86.7 percent increase over losses of $(21.66) per share from the same period last year. The company reported $238.000 thousand in
04-01 05:50
Catheter Precision Acquires Remaining 80% Equity In Fly Flyte From Creatd; Financial Terms Undisclosed
Catheter Precision, Inc. (NYSE American: VTAK) today announced that it has completed the acquisition of the remaining 80.02% equity interest in Fly Flyte, Inc. ("Flyte") from Creatd, Inc. (OTCQB:CRTDD), resulting in 100%
03-10 20:06
Catheter Precision Divests Non-Core Assets As It Shifts Focus
Catheter Precision sells atherectomy catheter tech to sharpen focus on electrophysiology growth.
02-19 23:21
Catheter Precision Acquire 19.98% Equity In Aviation Operator Flyte; Financial Terms Not Disclosed
Catheter Precision, Inc. (NYSE:VTAK) today announced a strategic minority investment in Fly Flyte, Inc. ("Flyte"), an FAA-certified regional aviation operator utilizing AI-enabled operations and a growing fleet of Cirrus
02-17 20:47
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers CytoMed Therapeutics (NASDAQ:GDTC) shares moved upwards by 6.9% to $1....
02-14 05:06
Catheter Precision Announces Increase In Hospital Evaluations, Approvals For Its LockeT Suture Retention Device
Catheter Precision, Inc. (NYSE American: VTAK), a medical device company specializing in advanced electrophysiology solutions, today announced a surge in hospital evaluations and approvals for its LockeT suture retention
02-04 21:11
